Henrietta Lacks

Henrietta Lacks was a Black woman whose cancer cells, taken without her knowledge or consent at Johns Hopkins Hospital in 1951, became the first immortal human cell line and a cornerstone of modern biomedical research. The HeLa cells grown from her tissue have been used in the development of the polio vaccine, cancer therapies, in vitro fertilization techniques, gene mapping and countless commercial products, meaning that a single woman’s living biology has shaped the health landscape of the entire world. Born Henrietta Pleasant in Roanoke, Virginia, in 1920 and raised in the tobacco country of Clover after her mother’s death, she lived within the segregated, underfunded health system reserved for Black Southerners. Like many Black families of her era, the Lacks and Pleasant kin relied on home remedies, church networks and sporadic access to charity hospitals, shaped by Jim Crow law and the economic precarity of tobacco labor. By the time she moved to Turner Station near Baltimore with her husband David ‘Day’ Lacks, she was part of a Black working‑class community dependent on Johns Hopkins—the one hospital in the region accepting Black patients—for serious care. In January 1951, after reporting severe pelvic pain and abnormal bleeding, Lacks was admitted to the segregated “colored” ward at Johns Hopkins and diagnosed with an aggressive cervical carcinoma. During a biopsy, physicians removed small tissue samples from her tumor and from healthy cervical tissue and passed them to researcher George Gey, who had spent years trying to grow human cells that would replicate indefinitely. Without informing Lacks, Gey’s lab placed the samples in culture; her cancer cells not only survived but multiplied rapidly, becoming the first human cell line to thrive continuously in vitro.

1.Life, Community and Medical Encounter

Henrietta Lacks grew up in a post‑emancipation rural Virginia landscape where Black families labored as tenant farmers and sharecroppers in tobacco fields that had once been worked by enslaved people. Her childhood was marked by extended kin networks and Black church life, and by schools and clinics that were underfunded by design. After her marriage to David Lacks, the couple joined the Great Migration stream to the industrial outskirts of Baltimore, settling in Turner Station, a Black community tied to Bethlehem Steel’s Sparrows Point plant.

Like many Black workers, the Lacks family navigated a health system shaped by segregation. Johns Hopkins Hospital, while more open to Black patients than many institutions, maintained segregated wards and unequal standards of care. Charity hospital status meant that poor Black patients were often treated as teaching and research material as much as recipients of care, a practice rarely explained to them in the language of research ethics.

2.The Birth of HeLa Cells

During Lacks’s treatment for cervical cancer, samples from her tumor and healthy tissue were sent to George Gey’s tissue culture lab. For years, Gey and his colleagues had struggled to keep human cells alive long enough in culture to be useful for experiments; most lines died after a few divisions. Lacks’s tumor cells, however, divided at a phenomenal rate and showed no signs of senescence, quickly growing into what became known as the HeLa cell line—a name derived from the first letters of her first and last name but initially treated in the scientific literature as an anonymized tag.

HeLa cells were soon shared widely, at first informally between academic labs and later through dedicated cell repositories. Their robustness made them ideal for testing radiation effects, studying cancer biology, exploring viral infection pathways and trying out new drugs. The cells allowed researchers to standardize experiments across laboratories in ways previously impossible, anchoring a shift from sporadic tissue studies to large‑scale, reproducible cell‑based science.

3.Scientific and Commercial Uses of HeLa

HeLa cells played a critical role in the development of the Salk polio vaccine in the 1950s, enabling mass testing of vaccine batches for efficacy and safety. They were used to study the effects of space travel on human biology, sent on early space missions to examine how cells respond to zero gravity and cosmic radiation. HeLa lines contributed to research into cancer chemotherapies, enabling researchers to screen compounds against a stable human tumor model.

Over subsequent decades, HeLa cells became a staple of research into virology, including studies of HIV and other pathogens, and into reproductive technologies such as in vitro fertilization and cloning. They were instrumental in efforts to map and understand the human genome, providing a consistent cellular substrate for genetic analysis. Commercial firms began selling HeLa cultures, turning Lacks’s tissue into a commodity that generated profits for companies and facilitated patentable discoveries, even though neither she nor her family had been compensated or consulted.

4.Consent, Race and Bioethics

At the time Lacks’s tissue was taken, there were no robust legal requirements for informed consent in research, and institutional norms often treated patients, particularly poor and Black patients, as sources of tissue without full explanation. The fact that her cells were harvested, multiplied and distributed globally without her knowledge reflects the racial and class power dynamics of mid‑twentieth‑century American medicine: Black bodies were seen as available resources, and their communities were kept largely ignorant of how their tissue was used.

When HeLa cells were first publicly associated with Lacks’s name in the 1970s, it was without clear communication with her family and against a backdrop of wider mistrust generated by abuses such as the Tuskegee syphilis study. The Lacks family discovered that their mother’s cells were everywhere—from freezers in university labs to corporate catalogs—and that scientists were publishing genetic information derived from HeLa without considering the privacy or dignity of living relatives. This realization sparked anger, confusion and a long struggle to reclaim some measure of control.

5.Family Activism and Rewriting the Record

In the late twentieth and early twenty‑first centuries, members of the Lacks family, working with Black journalists, scholars and ethicists, began pressing for recognition and ethical redress. They demanded that Henrietta’s name be acknowledged in scientific narratives, that her story be taught alongside discussions of informed consent and research ethics, and that there be some framework for protecting their privacy and interests as genetic databases expanded.

Their advocacy contributed to changes in how genetic data tied to HeLa cells is managed, including agreements over the use of HeLa genome sequences. It also helped reshape public understanding: popular books, documentaries, church memorials and community events reframed HeLa not as a neutral lab tool but as the living legacy of a Black woman whose existence had been reduced to code letters.

Black‑authored scholarship situates Lacks’s story within a longer history of extraction from Black bodies, connecting it to enslaved medical experimentation and segregated hospital practices. The archive recognizes the Lacks family as co‑authors of this reframed narrative: by insisting on their mother’s humanity, they have forced institutions to confront the ethical debts embedded in their scientific success.

6.Memory, Misattribution and the Archive’s Position

For decades, scientific papers and industry materials referred to HeLa cells without naming Henrietta Lacks, perpetuating a myth of the cell line as an abstract resource rather than the living tissue of a particular person. When her name did appear, she was often framed as a passive subject or even misidentified, and narratives rarely foregrounded the racial and economic context that made non‑consensual tissue use possible.

The archive rejects readings that treat her as incidental to the history of science. It holds that every breakthrough built on HeLa cells carries a traceable debt to Lacks and to the Black communities whose bodies have been mined for knowledge. Recognizing her authorship does not diminish the contributions of scientists; it restores the foundation upon which their work was built and insists that future innovation reckon openly with the histories of exploitation it inherits.

The family archive is admissible here. Photographs, letters, deeds, church programs, funeral bulletins, business records, recordings — the things that were kept when no institution was keeping them. A keeper reviews everything before it is admitted, and your name stays on it.

8.References